Occurrence of metabolic syndrome in midlife in relation to cardiovascular morbidity and all-cause mortality—lessons from a population-based matched cohort study with 27 years follow-up
The risk of a CV event and premature death is significantly increased when MetS is present. Early detection of metabolic risk factors, especially, high blood pressure, opens a window of opportunity to introduce preventive treatment to reduce CV morbidity and all-cause mortality.
Authors
- John Öhrvik (ORCID: https://orcid.org/0000-0002-6833-8783)
- Jerzy Leppert (ORCID: https://orcid.org/0000-0003-1433-0329)
- Mattias Rehn (ORCID: https://orcid.org/0000-0001-9927-2660)
- Lena Lönnberg (ORCID: https://orcid.org/0000-0003-4706-6915)
- Mattias Damberg (ORCID: https://orcid.org/0000-0001-7654-7553)
- Abbas Chabok (ORCID: https://orcid.org/0000-0001-9662-5045)
Institutions
- Uppsala University (SE)
- Uppsala University Hospital (SE)
- Danderyds sjukhus (SE)
Publication Details
- Journal
- BMJ Open
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1136/bmjopen-2023-081444
- Citations
- 2
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.72